Mechanistic insights into the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary Syndrome: associationwith disease course and treatment response
Mechanistic insights into the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary Syndrome: associationwith disease course and treatment response
Tipologia
Progetti internazionali
Ente finanziatore
Cutaneous Lymphoma Foundation
Budget
€ 41.240,51
Responsabile
Pietro Quaglino
Partecipanti al progetto
- Quaglino Pietro (Responsabile)